Atrial fibrillation: paroxysmal: patients felt better with AV junction ablation and a pacemaker rather than AV junction modification
|
|
|
Clinical bottom line (level 1b)
-
Patients with paroxysmal atrial fibrillation resistant to medical therapy who received a complete AV junction ablation and a permanent pacemaker compared with AV junction modification had fewer significant symptoms and felt they had a better quality of life.
|
|
Lee et al:
Journal of the American College of Cardiology
1998;
31 (3):
637-644
|
Expires
November 2003
|
The study
Unblinded ?concealed randomised
trial
with
intention-to-treat
Setting: acute hospital, Taiwan
60 patients
(aged
mean 67,
75%
male)
with medically refractory paroxysmal atrial fibrillation or chronic atrial fibrillation
Excluded if
indication for a permanent pacemaker (AF with long pauses or symptomatic bradycardia)
Control Group: (n = 30, 30 analysed):
complete AV junction ablation with permanent pacing
Experimental Group: (n = 30, 30 analysed):
AV junction modification
100% followed for
15
months
The evidence
| Outcome |
Control Group (SD) |
Experimental Group (SD) |
Mean Difference (95% CI) |
| frequency of significant attacks
|
0.70
(0.80)
|
1.40
(0.90)
|
0.7
(0.3 to 1.1)
|
| general quality of life
|
1.0
(0.80)
|
1.70
(0.70)
|
0.7
(0.3 to 1.1)
|
Comments
- All patients had an improvement in symptoms following therapy.
- Quality of life was scored from 0 to 3 (no symptoms to severe symptoms).
Citation
-
Lee
S-H,
Chen
S-A,
Tai
C-T, et al:
Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation.
Journal of the American College of Cardiology
1998;
31 (3):
637-644
Search Terms:
?
Contributor: Chris Ball and Clare Wotton,
November 1999
Reviewer:
Clinical Question.
| Patient |
paroxysmal atrial fibrillation resistant to medical therapy |
| Intervention or Exposure |
AV junction modification |
| Comparison |
AV junction ablation with permanent pacemaker |
| Outcome |
frequency of attacks and quality of life |
|
|